![SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice - ScienceDirect SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1553838921000853-gr1.jpg)
SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice - ScienceDirect
![First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial ... First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial ...](https://ars.els-cdn.com/content/image/1-s2.0-S1553838919301526-gr4.jpg)
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial ...
![SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice - ScienceDirect SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1553838921000853-gr2.jpg)
SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice - ScienceDirect
![Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca](https://www.giornaledicardiologia.it/allegati/03311_2020_02/images/imgs_30.jpg)
Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca
![PDF) BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients PDF) BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients](https://i1.rgstatic.net/publication/344087146_BIOSOLVE-IV-registry_Safety_and_performance_of_the_Magmaris_scaffold_12-month_outcomes_of_the_first_cohort_of_1075_patients/links/5f6a2c2b299bf1b53ee9b4de/largepreview.png)
PDF) BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients
Mechanical properties of the drugâ•'eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a perman
![First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial ... First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial ...](https://ars.els-cdn.com/content/image/1-s2.0-S1553838919301526-gr2.jpg)
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial ...
![Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds | Circulation: Cardiovascular Interventions Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/d246df47-0b73-48df-b5db-8065945ceba1/e004762fig02.jpg)
Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds | Circulation: Cardiovascular Interventions
Mechanical properties of the drugâ•'eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a perman
![Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca](https://www.giornaledicardiologia.it/allegati/03311_2020_02/images/imgs_26.jpg)
Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca
Mechanical properties of the drugâ•'eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a perman
![Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent - Barkholt - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent - Barkholt - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2f277a48-70f5-459b-a6ba-16b15fd562af/ccd28545-fig-0003-m.jpg)
Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent - Barkholt - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library
![Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent - Barkholt - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent - Barkholt - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d7df4cc2-abb0-4837-9c16-54447d407d58/ccd28545-fig-0001-m.jpg)
Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent - Barkholt - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Mechanical properties of the drugâ•'eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a perman
![Impact of strut dimensions and vessel caliber on thrombosis risk of bioresorbable scaffolds using hemodynamic metrics Impact of strut dimensions and vessel caliber on thrombosis risk of bioresorbable scaffolds using hemodynamic metrics](https://www.degruyter.com/document/doi/10.1515/bmt-2017-0101/asset/graphic/j_bmt-2017-0101_fig_001.jpg)